tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:AGN Stock Latest News

Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
Company AnnouncementsArgenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
2d ago
AGN
Argenica Therapeutics Announces Departure of Director Di Angus
PremiumCompany Announcements
Argenica Therapeutics Announces Departure of Director Di Angus
28d ago
AGN
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
PremiumCompany Announcements
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
1M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
PremiumCompany Announcements
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
2M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
PremiumCompany Announcements
Argenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
2M ago
AGN
Argenica Therapeutics AGM Resolutions Passed Successfully
PremiumCompany AnnouncementsArgenica Therapeutics AGM Resolutions Passed Successfully
3M ago
AGN
Argenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
Premium
Company Announcements
Argenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
3M ago
AGN
Argenica Therapeutics Announces Retirement of Key Board Member
Premium
Company Announcements
Argenica Therapeutics Announces Retirement of Key Board Member
3M ago
AGN
Argenica Therapeutics Advances Stroke Treatment with Promising Trial Results
PremiumCompany Announcements
Argenica Therapeutics Advances Stroke Treatment with Promising Trial Results
3M ago
AGN
Argenica Therapeutics Issues New Equity Securities as Part of Employee Incentive Scheme
PremiumCompany Announcements
Argenica Therapeutics Issues New Equity Securities as Part of Employee Incentive Scheme
3M ago
AGN
Argenica Therapeutics Reports Positive Phase 2 Trial Results for Stroke Treatment
PremiumCompany Announcements
Argenica Therapeutics Reports Positive Phase 2 Trial Results for Stroke Treatment
4M ago
AGN
Argenica Therapeutics Announces Details for Upcoming Annual General Meeting
PremiumCompany Announcements
Argenica Therapeutics Announces Details for Upcoming Annual General Meeting
4M ago
AGN
Argenica Therapeutics Unveils Strategic Presentation at ASX Conference
PremiumCompany AnnouncementsArgenica Therapeutics Unveils Strategic Presentation at ASX Conference
4M ago
AGN
Argenica Therapeutics Sets Date for Annual General Meeting
Premium
Company Announcements
Argenica Therapeutics Sets Date for Annual General Meeting
5M ago
AGN
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Results
Premium
Company Announcements
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Results
5M ago
AGN
Argenica Therapeutics Unveils Phase 2 Trial Results
PremiumCompany Announcements
Argenica Therapeutics Unveils Phase 2 Trial Results
5M ago
AGN
Argenica Therapeutics Reports Promising Phase 2 Results for Stroke Treatment ARG-007
PremiumCompany Announcements
Argenica Therapeutics Reports Promising Phase 2 Results for Stroke Treatment ARG-007
5M ago
AGN
Argenica Therapeutics Initiates Trading Halt Ahead of Clinical Trial Results
PremiumCompany Announcements
Argenica Therapeutics Initiates Trading Halt Ahead of Clinical Trial Results
5M ago
AGN
Argenica Therapeutics Releases 2025 Corporate Governance Statement
PremiumCompany Announcements
Argenica Therapeutics Releases 2025 Corporate Governance Statement
5M ago
AGN
Argenica Therapeutics Reports Revenue Growth Amid Rising R&D Costs
PremiumCompany AnnouncementsArgenica Therapeutics Reports Revenue Growth Amid Rising R&D Costs
5M ago
AGN
Argenica Therapeutics Addresses FDA’s Clinical Hold on Stroke Treatment
Premium
Company Announcements
Argenica Therapeutics Addresses FDA’s Clinical Hold on Stroke Treatment
6M ago
AGN
Argenica Therapeutics Cautions Investors with New Presentation
Premium
Company Announcements
Argenica Therapeutics Cautions Investors with New Presentation
6M ago
AGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >